Targeting the TAM Receptors in Leukemia
Targeted inhibition of members of the TAM (TYRO-3, AXL, MERTK) family of receptor tyrosine kinases has recently been investigated as a novel strategy for treatment of hematologic malignancies. The physiologic functions of the TAM receptors in innate immune control, natural killer (NK) cell different...
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126761/ |